Received Mar 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y016872 | — |
No additional AE; HCP called to report a dose of PROQUAD was given to a 9-month-old patient.; This spontaneous report was received from a physician and refers to a 9-month-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 05-Mar-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y016872, expiration date: 07-Apr-2026) 0.5 mL, diluted in sterile diluent (MERCK STERILE DILUENT), 0.5 mL (expiration date, and lot # were not reported) for prophylaxis (Inappropriate age at vaccine administration). Healthcare provider (HCP) stated he intended to administer the child the vaccine dose for upcoming international travel as the parents were concerned about MMR outbreaks. No symptoms reported.
DILUENT MRK